119 related articles for article (PubMed ID: 8443419)
1. Clinico-pathological correlations in meningiomas: a DNA and immunohistochemical study.
Cruz-Sánchez FF; Miquel R; Rossi ML; Figols J; Palacín A; Cardesa A
Histol Histopathol; 1993 Jan; 8(1):1-8. PubMed ID: 8443419
[TBL] [Abstract][Full Text] [Related]
2. [DNA analysis of meningiomas using paraffin-embedded surgical specimens in connection with clinical recurrence].
Akachi K; Matsumoto M; Yasue M; Nakamura N; Kamada M; Ohno T
No Shinkei Geka; 1991 Dec; 19(12):1129-34. PubMed ID: 1766537
[TBL] [Abstract][Full Text] [Related]
3. MIB-1 immunostaining and DNA flow cytometry in meningiomas.
Yasue M; Akasaki Y; Numoto TR; Abe S; Abe T; Takeuchi Y; Tanaka J
Noshuyo Byori; 1996 Apr; 13(1):17-20. PubMed ID: 8916122
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
5. Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior.
Appley AJ; Fitzgibbons PL; Chandrasoma PT; Hinton DR; Apuzzo ML
Neurosurgery; 1990 Jul; 27(1):83-96. PubMed ID: 2377285
[TBL] [Abstract][Full Text] [Related]
6. CD44 expression in human meningiomas: an immunohistochemical analysis.
Lewy-Trenda I; Omulecka A; Janczukowicz J; Papierz W
Pol J Pathol; 2004; 55(1):33-7. PubMed ID: 15195704
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
[TBL] [Abstract][Full Text] [Related]
8. Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas.
Torp SH; Lindboe CF; Granli US; Moen TM; Nordtømme T
Clin Neuropathol; 2001; 20(5):190-5. PubMed ID: 11594503
[TBL] [Abstract][Full Text] [Related]
9. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
10. [Proliferative markers of meningiomas: immunohistochemical analysis and prognostic value].
Korshunov AG; Shishkina LV; Golanov AV
Arkh Patol; 2002; 64(1):29-33. PubMed ID: 11889696
[TBL] [Abstract][Full Text] [Related]
11. [Flow cytometry in the study of meningiomas. Preliminary results and attempt at clinical correlation].
Kujas M; Rateau JG; Bruch JF; Van Effenterre R
Arch Anat Cytol Pathol; 1996; 44(2-3):77-82. PubMed ID: 8794584
[TBL] [Abstract][Full Text] [Related]
12. Comparison of flow cytometric DNA content analysis of fresh and formalin-fixed paraffin-embedded solid neoplasms.
Kumar D; Kumar S; Lyon D
Mod Pathol; 1994 Apr; 7(3):354-60. PubMed ID: 8058708
[TBL] [Abstract][Full Text] [Related]
13. Correlation of histopathologic classification with proliferative activity and DNA ploidy in 120 intracranial meningiomas, with special reference to atypical meningioma.
Myong NH; Chi JG
J Korean Med Sci; 1997 Jun; 12(3):221-7. PubMed ID: 9250918
[TBL] [Abstract][Full Text] [Related]
14. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
Ozen O; Demirhan B; Altinörs N
Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
[TBL] [Abstract][Full Text] [Related]
15. Correlation of p63 immunoreactivity with tumor grade in meningiomas.
Rushing EJ; Olsen C; Man YG
Int J Surg Pathol; 2008 Jan; 16(1):38-42. PubMed ID: 18203782
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell cycle in patients with stage I endometrial carcinoma.
Vecek N; Nola M; Marusić M; Babić D; Uzarević B; Sabioncello A; Petrovecki M; Ljubić-Racunica N; Marinović T
Gynecol Oncol; 1994 Apr; 53(1):38-43. PubMed ID: 8175020
[TBL] [Abstract][Full Text] [Related]
18. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496
[TBL] [Abstract][Full Text] [Related]
19. Clear cell meningioma variant and clinical aggressiveness.
Pimentel J; Fernandes A; Pinto AE; Fonseca I; Moura Nunes JF; Lobo Antunes J
Clin Neuropathol; 1998; 17(3):141-6. PubMed ID: 9625306
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas.
Perry A; Stafford SL; Scheithauer BW; Suman VJ; Lohse CM
Cancer; 1998 Jun; 82(11):2262-9. PubMed ID: 9610708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
